| Identification | Back Directory | [Name]
3-(hexyloxy)-4-(pyridin-3-yl)-1,2,5-thiadiazole | [CAS]
131987-69-4 | [Synonyms]
Xanomeline Impurity 10
Xanomeline Impurity 13
Xanomeline intermediate 2
3-(Hexyloxy)-4-(3-pyridyl)-1,2,5-thiadiazole
3-(3-Hexyloxy-1,2,5-thiadiazol-4-yl)pyridine
3- (4-hydroxy-1,2,5-thiadiazol-3-yl) pyridine
3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]pyridine
3-(hexyloxy)-4-(pyridin-3-yl)-1,2,5-thiadiazole
Pyridine, 3-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-
3-(Hexyloxy)-4-(Pyridin-3-Yl)-1,2,5-Thiadiazole
3-(4--1,2,5 --3-) | [Molecular Formula]
C13H17N3OS | [MDL Number]
MFCD18074178 | [MOL File]
131987-69-4.mol | [Molecular Weight]
263.36 |
| Chemical Properties | Back Directory | [Melting point ]
48-50 °C(Solv: hexane (110-54-3)) | [Boiling point ]
366.6±27.0 °C(Predicted) | [density ]
1.143±0.06 g/cm3(Predicted) | [pka]
1.68±0.12(Predicted) |
|
| Company Name: |
BTC Pharmaceutical CO. Ltd Gold
|
| Tel: |
0513-68015397;15716293042 18862997610;18862996710 |
| Website: |
http://www.btcpharm.com |
|